CD163 and Obesity: As of yet, associations of sMR in obesity and diabetes have not been described, whereas sCD163 levels are increased in both obesity and type 2 diabetes and, hence, given that our cohort is both leaner and nondiabetic it may explain why our intervention with liraglutide does not reduce sCD163 levels.